Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the Gd(III) chelates.
about
MRI detection of VEGFR2 in vivo using a low molecular weight peptoid-(Gd)8-dendron for targetingLanthanide probes for bioresponsive imagingDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agentGd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.Amphiphilic EuDOTA-tetraamide complexes form micelles with enhanced CEST sensitivity.Dysprosium complexes and their micelles as potential bimodal agents for magnetic resonance and optical imaging.Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.Micellar self-assemblies of gadolinium(III)/europium(III) amphiphilic complexes as model contrast agents for bimodal imaging.Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability.High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation.Magnetofluorescent micelles incorporating Dy(III)-DOTA as potential bimodal agents for optical and high field magnetic resonance imaging.Amphiphilic Ditopic Bis-Aqua Gd-AAZTA-like Complexes Enhance Relaxivity of Lipidic MRI Nanoprobes.Developing the family of picolinate ligands for Mn2+ complexation.Enhancing T1 magnetic resonance imaging contrast with internalized gadolinium(III) in a multilayer nanoparticleRedox-triggered self-assembly of gadolinium-based MRI probes for sensing reducing environmentGold nanoparticles functionalised with stable, fast water exchanging Gd3+ chelates as high relaxivity contrast agents for MRI.Structure - relaxivity relationships among targeted MR contrast agents.Caspase-responsive smart gadolinium-based contrast agent for magnetic resonance imaging of drug-induced apoptosisA R2p /R1p ratiometric procedure to assess matrix metalloproteinase-2 activity by magnetic resonance imaging.Heteroditopic binding of magnetic resonance contrast agents for increased relaxivity.Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent.Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imagingProbing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRIGd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.Shape-Dependent Relaxivity of Nanoparticle-Based T1 Magnetic Resonance Imaging Contrast Agents.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.Mesoporous silica nanoparticles as nanocarriers.The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.Environmentally responsive MRI contrast agents.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging.Target binding improves relaxivity in aptamer-gadolinium conjugates.Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging.Mesoporous silica nanoparticles functionalized with fluorescent and MRI reporters for the visualization of murine tumors overexpressing αvβ3 receptors.
P2860
Q24619870-FBDE5F71-06D9-4614-9F77-D62AF7CC825CQ27000361-1CCEAED5-913E-4370-8BFB-CB450D166F42Q28235682-712F47E8-9B88-4E1E-8752-5B5647103F63Q30354652-FE8AE530-FDA0-4498-BF44-7ECF3813E622Q30361067-898E5EAC-2E5A-4264-9D22-56A4976D62D1Q30571105-DA10A56F-3C9F-4208-8EDD-49B9551C7CCFQ30576125-D246E126-3595-4423-8C75-323DCB8F0F63Q30577667-7CBEE322-9EB7-45C9-B199-8C62166FDCAEQ30586879-09F37E81-5287-4DC3-B798-90CF211BEDB0Q30677097-208F5E3F-255F-4E76-B6F1-93686F64CC4EQ30716845-BE7EE15A-7D33-47A0-8A21-C82B524A6900Q30729090-3EB4E102-B6A6-4A0D-848D-C70551747605Q30751363-B9A76D82-CADE-4383-98ED-E7A9EF463084Q30901328-F6B7847F-915A-4C42-B46E-0589B6615B81Q31044226-6727BEAF-B6E3-4039-A039-0DE58E7E3A6EQ31109393-261F3C7B-889A-4424-BA7B-14DFDE421D67Q31154865-F42AE8B1-4526-4214-AC49-F3E5B40A8DFAQ33887027-EFB76AB7-9277-4EC2-8A6E-EB04FE52E2BAQ34074857-CE8F78B5-4E56-4EF9-A399-F3D27E68C35DQ34216365-AFCD6F28-EEED-40CC-91ED-5914178DA3A1Q34320982-22DD4AAB-AB60-4D5C-A047-7EFFBD53D1F2Q34560497-C9D76753-64B8-479A-A8F8-C0C12FB3D06FQ34602149-9711D1F3-EB0B-41C0-948C-D86972C05AEBQ35249665-2A9761D1-8288-4A4B-B15D-D8FB63E28EABQ35637325-7979785F-A681-4576-8E81-AB87F1F6B462Q36460517-6E0C80C9-B4DD-470C-9F63-92593DD7C5A0Q36592997-404A77E7-975A-48F2-97FD-A789A2689E4CQ36671358-05D46E1F-1067-45B7-A2FB-0D2B941F4EE4Q36915069-89F7A603-890A-43A7-A337-4A509EC852C3Q37142843-B7079AC1-CE11-4AAB-BA32-9398AA1CDE7AQ37519978-FADFDBE7-F715-46C0-AFE6-79D31C44684DQ37850696-FDD29D1F-80C6-4EE3-AF7E-5FBFCB6C6F2AQ37895950-1DCF7029-BAA0-4924-AA87-2EB353D678F6Q38080002-1B2B22DD-4BAA-42CD-8E44-390330E33DD3Q38138098-E0AC1D77-0D1A-4416-95F3-0F594EBB1281Q38155457-930FC92E-1D16-479B-B05D-751CE5C975EAQ38248318-E4491E7F-8F87-4257-9A18-06B2EF0CA8A8Q38322510-A23CB32F-6307-46C9-903F-A014BBE539D1Q38740522-0173DA28-29FD-44BC-A048-5FF3AD4A2CC8Q38787542-D269E7EE-71E0-46E2-BE4B-43ADBDA783BE
P2860
Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the Gd(III) chelates.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Large relaxivity enhancement o ...... ng the local motions of the Gd
@nl
Large relaxivity enhancement o ...... tions of the Gd(III) chelates.
@ast
Large relaxivity enhancement o ...... tions of the Gd(III) chelates.
@en
type
label
Large relaxivity enhancement o ...... ng the local motions of the Gd
@nl
Large relaxivity enhancement o ...... tions of the Gd(III) chelates.
@ast
Large relaxivity enhancement o ...... tions of the Gd(III) chelates.
@en
prefLabel
Large relaxivity enhancement o ...... ng the local motions of the Gd
@nl
Large relaxivity enhancement o ...... tions of the Gd(III) chelates.
@ast
Large relaxivity enhancement o ...... tions of the Gd(III) chelates.
@en
P50
P356
P1476
Large relaxivity enhancement o ...... tions of the Gd(III) chelates.
@en
P2093
Filip Kielar
P304
P356
10.1021/JA101518V
P407
P577
2010-06-01T00:00:00Z